Materials & Resources » Chemicals | Evogene Ltd.

Evogene Ltd.

Evogene Ltd.
Stock Exchange New York Stock Exchange
EPS
$0.74
Market Cap
$41.2 M
Shares Outstanding
24.96 M
Public Float
-

Profile

Address
Park Rehovot
Rehovot HM 76120
Israel
Employees -
Website http://www.evogene.com
Updated 07/08/2019
Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities.

Financials

View All
Created with Highcharts 5.0.14Evogene Ltd.Net Income. Fiscal year is January-December. All values ILS Thousands.32 04532 04551 97651 97666 87666 87675 20975 20974 95374 95374 63074 630201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Evogene Ltd.Sales/Revenue. Fiscal year is January-December. All values ILS Thousands.63 45863 45851 90851 90843 23843 23825 10525 10512 16112 1616 2806 280201320142015201620172018020k40k60k80k

Martin S. Gerstel
Chairman
Sarit Firon
Independent Director